RxDoctor Payments Data

Megan Mulligan

Psychiatric/Mental Health · Poland, OHNPI 1629783774

Payments from drug & device makers

$1,167in general payments, 2019–2025

Across 48 payments — averaging $24.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vanda Pharmaceuticals Inc.$255
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$199
  • AbbVie$169
  • Axsome Therapeutics, Inc.$125
  • Otsuka America Pharmaceutical, Inc.$106
  • Takeda Pharmaceuticals U.S.A., Inc.$75
  • plus $238 from 7 others

What the payments were for

  • Food & beverage$1,12897%
  • Education$393%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,167 in reported general payments places this provider in the 60th percentile of 1,808 psychiatric/mental health providers in Ohio.

See all psychiatric/mental health providers in Ohio

Medicare billing

Part B allowed, 2024
$10,277
Medicare patients
41
Services billed
124

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AuvelityDextromethorphan Hbr/Bupropion11$13,935
VraylarCariprazine Hcl11$12,039
VyvanseLisdexamfetamine Dimesylate14$5,996
Aripiprazole35$1,077
Ziprasidone Hcl15$790
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine23$776
Duloxetine Hcl49$769
Amitriptyline Hcl31$604
Fluoxetine Hcl14$511
Hydroxyzine Hcl35$504
Buspirone Hcl42$442
Prazosin Hcl28$308
Olanzapine13$295
Quetiapine Fumarate22$244
Divalproex Sodium20$238

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Axsome Therapeutics, Inc.Auvelity$125$13,93511 claims
AbbVieVraylar$169$12,03911 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$75$5,99614 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,808 psychiatric/mental health providers in Ohio.

Other psychiatric/mental health in Poland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →